>중동 및 아프리카 e-Clinical Solutions 시장, 제품별(전자 데이터 캡처 및 임상 시험 데이터 관리 시스템, 임상 시험 관리 시스템, 임상 분석 플랫폼, 케어 조정 의료 기록(CCMR), 무작위화 및 시험 공급 관리, 임상 데이터 통합 플랫폼, 전자 임상 결과 평가 솔루션, 안전 솔루션, 전자 시험 마스터 파일 시스템, 규제 정보 관리 솔루션 및 기타), 제공 모드(웹 호스팅(주문형) 솔루션, 라이선스 엔터프라이즈(온프레미스) 솔루션 및 클라우드 기반(SAAS) 솔루션), 임상 시험 단계(1상, 2상, 3상 및 4상), 조직 규모(소규모 및 중규모 및 대규모), 사용자 장치(데스크톱, 태블릿, 핸드헬드 PDA 장치, 스마트 폰 및 기타), 최종 사용자(제약 및 바이오제약 회사, 계약 연구 기관, 컨설팅 서비스 회사, 의료 기기 제조업체, 병원 및 학술 연구 기관), 산업 동향 및 예측 2030년.
중동 및 아프리카 e-Clinical Solutions 시장 분석 및 규모
중동 및 아프리카 e-임상 솔루션 시장은 Oracle, IQVIA Inc., Dassault Systemes, Clario 등과 같은 많은 글로벌 기업으로 구성되어 있기 때문에 분산되어 있습니다. 이러한 기업의 존재는 지역 전체의 시스템 서비스 및 소프트웨어에 대한 경쟁력 있는 가격을 제공합니다. 지역 및 국제 수준에서 이러한 기업이 존재하기 때문에 공급업체와 제조업체는 모든 예산에서 다양한 사양과 특성을 가진 제품을 제공합니다. 전자 데이터 캡처(EDC) 시스템과 클라우드 기반 채택이 증가함에 따라 시장 성장이 촉진되고 있습니다. 또한 환자 중심 임상 시험에 대한 집중이 커지면서 시장 성장이 촉진될 것으로 예상됩니다.
Data Bridge Market Research는 중동 및 아프리카 e-임상 솔루션 시장이 2030년까지 1,082.15백만 달러에 도달할 것으로 예상되며, 예측 기간 동안 CAGR은 11.9%가 될 것으로 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.
보고서 메트릭 |
세부 |
예측 기간 |
2023년부터 2030년까지 |
기준 연도 |
2022 |
역사적 연도 |
2021 (2015~2020년까지 사용자 정의 가능) |
양적 단위 |
매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨 |
다루는 세그먼트 |
By Product (Electronic Data Capture and Clinical Trial Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Care Coordination Medical Records (CCMR), Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, and Others), Delivery Mode (Web-Hosted (On- Demand) Solutions, Licensed Enterprise (On-Premises) Solutions, and Cloud-Based (SAAS) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Small & Medium and Large), User Device (Desktop, Tablet, Handheld PDA Device, Smart Phone, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutes) |
Countries Covered |
South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and the Rest of the Middle East and Africa |
Market Players Covered |
Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager, Datatrack Int., and IQVIA Inc.
|
Market Definition
The goal of e-clinical solutions is to revolutionize the field of clinical research. The clinical management organization is trying to improve the effectiveness, efficiency, and accessibility of clinical research data to treat patients more quickly. The idea behind the creation of eClinical Solutions was to pinpoint the problems with clinical research data, fix them, and offer creative solutions to make clinical trial data useful and simple to obtain, as well as to facilitate the standardization, reporting, and operation of the clinical research domain. The rising adoption and growing focus on e-clinical solutions and software are expected to drive market growth.
The e-clinical solutions, such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF) systems, are software programs used in clinical research to manage clinical data. However, strict regulations and standards for the approval of clinical trial studies and product approvals are expected to restrain market growth.
Middle East and Africa e-Clinical Solutions Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Increasing R&D activities and corresponding expenditure
Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.
The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.
Improved healthcare infrastructure and establishment of advanced laboratories
Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.
Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.
OPPORTUNITY
Increasing investments by various governments in clinical trials
Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.
RESTRAINT / CHALLENGE
Data Safety and Privacy issues
Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.
Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the Middle East and Africa e-clinical solutions market and is expected to hamper market growth.
Post-COVID-19 Impact on the Middle East and Africa e-Clinical Solutions Market
COVID-19 positively impacted the Middle East and Africa e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.
However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth has been high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
- In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering
Middle East and Africa e-Clinical Solutions Market Scope
The Middle East and Africa e-clinical solutions market is segmented into six notable segments based on product, delivery mode, clinical trial phase, organization size, user device, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Care Coordination Medical Record (CCMR)
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
Based on product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems, clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions and others.
Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premises) Solutions
- Cloud-based (SAAS) Solutions
Based on delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.
Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Based on clinical trial phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.
Organization Size
- Small & Medium
- Large
Based on organization size, the market is segmented into small & medium, and large.
User Device
- Desktop
- Tablet
- Handheld PDA Device
- Smart Phone
- Others
Based on user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.
End User
- Pharmaceutical and Biopharmaceutical companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.
Middle East and Africa e-Clinical Solutions Market Regional Analysis/Insights
The Middle East and Africa e-clinical solutions market is analyzed, and market size information is p based on product, delivery mode, clinical trial phase, organization size, user device, and end user.
The countries covered in this market report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and the Rest of the Middle East and Africa.
남아프리카공화국은 전자 데이터 수집 시스템과 클라우드 기반 솔루션 도입이 증가함에 따라 중동과 아프리카 지역을 장악할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 추세에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제와 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 중동 및 아프리카 e-Clinical Solutions 시장 점유율 분석
중동 및 아프리카 e-임상 솔루션 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 세부 정보에는 회사 개요, 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우위가 포함됩니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
중동 및 아프리카 e-임상 솔루션 시장에서 활동하는 주요 시장 주체로는 Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S FIVE FORCES MODEL
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS
4.3 USE CASES
5 VALUE CHAIN ANALYSIS
6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES
7.2 RESTRAINTS
7.2.1 DATA SAFETY AND PRIVACY ISSUES
7.2.2 LACK OF SKILLED PROFESSIONALS
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES
7.3 OPPORTUNITIES
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS
7.4 CHALLENGES
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS
7.4.2 HIGH IMPLEMENTATION COSTS
8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
8.7 SAFETY SOLUTIONS
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
8.9 CLINICAL DATA INTEGRATION PLATFORMS
8.1 CLINICAL ANALYTICS PLATFORMS
8.11 CARE COORDINATION MEDICAL RECORD (CCMR)
8.12 OTHERS
9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
9.3 CLOUD-BASED (SAAS) SOLUTIONS
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
10 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
10.1 OVERVIEW
10.2 PHASE III
10.3 PHASE I
10.4 PHASE II
10.5 PHASE IV
11 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE
11.1 OVERVIEW
11.2 MEDIUM AND SMALL
11.3 LARGE
12 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE
12.1 OVERVIEW
12.2 DESKTOP
12.3 TABLET
12.4 SMART PHONE
12.5 HANDHELD PDA DEVICE
12.6 OTHERS
13 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER
13.1 OVERVIEW
13.2 CONTRACT RESEARCH ORGANIZATIONS
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
13.4 MEDICAL DEVICE MANUFACTURERS
13.5 HOSPITAL
13.6 CONSULTING SERVICE COMPANIES
13.7 ACADEMIC RESEARCH INSTITUTES
14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY REGION
14.1 MIDDLE EAST AND AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E.
14.1.4 EGYPT
14.1.5 ISRAEL
14.1.6 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ORACLE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 DASSAULT SYSTEMES
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 CLARIO
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 VEEVA SYSTEMS
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 ARISMIDDLE EAST & AFRICA
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 4G CLINICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ADVARRA.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANJU
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 CASTOR.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 DATATRAK INT.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 ECLINICAL SOLUTIONS LLC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 IQVIA INC
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 MAXISIT
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 MEDNET
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 MEDRIO, INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 MERATIVE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 OPENCLINICA, LLC
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PAREXEL INTERNATIONAL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 QURETEC
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 REALTIME SOFTWARE SOLUTIONS, LLC
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 RESEARCH MANAGER
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SAAMA TECHNOLOGIES, LLC
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SIGNANT HEALTH
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 Y-PRIME, LLC.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 THE COSTS OF IMPLEMENTATION ARE AS FOLLOWS, ACCORDING TO SIMPLETRIALS:
TABLE 2 ACCORDING TO ECLINICAL WORKS – ECLINICAL OFFERS TWO ENTERPRISE PRICING PACKAGES:
TABLE 3 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA CLINICAL TRIAL MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA ELECTRONIC TRIAL MASTER FILE SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA SAFETY SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CLINICAL DATA INTEGRATION PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA CLINICAL ANALYTICS PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CARE COORDINATION MEDICAL RECORD (CCMR) IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA WEB-HOSTED (ON-DEMAND) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA CLOUD-BASED (SAAS) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA PHASE III IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA PHASE I IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA PHASE II IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA PHASE IV IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA MEDIUM AND SMALL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA LARGE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA DESKTOP IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA TABLET IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SMART PHONE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA HANDHELD PDA DEVICE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA HOSPITAL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA CONSULTING SERVICE COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA ACADEMIC RESEARCH INSTITUTES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 49 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 50 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 51 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 52 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 55 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 56 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 57 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 59 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 61 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 62 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 63 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 64 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 65 EGYPT E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 EGYPT E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 67 EGYPT E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 68 EGYPT E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 69 EGYPT E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 70 EGYPT E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 73 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 74 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 75 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 76 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 REST OF MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA E- CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 11 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS AS WELL AS INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE, IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA E- CLINICAL SOLUTIONS MARKET FROM 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET
FIGURE 14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2022
FIGURE 15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2022
FIGURE 19 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2022
FIGURE 23 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2022
FIGURE 27 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2022
FIGURE 31 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2022
FIGURE 35 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 39 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 40 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 43 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.